Inventor · disambiguated record
Michael Ollmann
Also filed as: OLLMANN MICHAEL · OLLMANN MICHAEL M · OLLMANN MICHAEL MARTIN
7 granted patents·15 pending applications·183 citations·filing 2001–2025
79Inventor score
Top patents by PatentIndex Score
22 records- 0195US6515109B1Human ECT2 polypeptideEXELIXIS INC·Filed 2001·Granted Feb 4, 2003·179 cites·1 claims
- 0276US6630297B2Methods of screening for agents that modulate the interaction of human ECT2 polypeptide with an ECT2 binding targetEXELIXIS INC·Filed 2002·Granted Oct 7, 2003·4 cites·10 claims
- 0367US11732266B2RNAi constructs for inhibiting ASGR1 expression and methods of use thereofAMGEN INC·Filed 2020·Granted Aug 22, 2023·0 cites·34 claims
- 0457US10870856B2RNAi constructs for inhibiting ASGR1 expression and methods of use thereofAMGEN INC·Filed 2017·Granted Dec 22, 2020·0 cites·36 claims
- 0556US2007274914A1Mptens as Modifiers of the Pten/Igf Pathway and Methods of UseEXELIXIS INC·Filed 2004·Application pending·0 cites
- 0656US2025320502A1Rnai constructs for inhibiting pnpla3 expression and methods of use thereofAMGEN INC·Filed 2025·Application pending·0 cites
- 0756US2025011779A1Compositions and methods for enhancing gene silencing activity of oligonucleotide compoundsAMGEN INC·Filed 2022·Application pending·0 cites
- 0856US2008163386A1CRBs as Modifiers of Branching Morphogenesis and Methods of UseEXELIXIS INC·Filed 2007·Application pending·0 cites
- 0955US2022017906A1Rnai constructs for inhibiting pnpla3 expression and methods of use thereofAMGEN INC·Filed 2019·Application pending·0 cites
- 1054US2023279399A1Rnai constructs for inhibiting hsd17b13 expression and methods of use thereofAMGEN INC·Filed 2021·Application pending·0 cites
- 1154US2025154512A1Rnai constructs for inhibiting pnpla3 expression and methods of use thereofAMGEN INC·Filed 2025·Application pending·0 cites
- 1252US2023078200A1RNAi CONSTRUCTS AND METHODS FOR INHIBITING LPA EXPRESSIONAMGEN INC·Filed 2020·Application pending·0 cites
- 1351US7927872B2ALDOs as modifiers of the IGF pathway and methods of useEXELIXIS INC·Filed 2005·Granted Apr 19, 2011·0 cites·15 claims
- 1451US2004161827A1Insect p53 tumor suppressor genes and proteinsFiled 2004·Application pending·0 cites
- 1551US2021139912A1Rnai constructs for inhibiting pnpla3 expression and methods of use thereofAMGEN INC·Filed 2018·Application pending·0 cites
- 1650US2003100005A1CRBs as modifiers of branching morphogenesis and methods of useFiled 2002·Application pending·0 cites
- 1750US2022307022A1Rnai constructs for inhibiting scap expression and methods of use thereofAMGEN INC·Filed 2020·Application pending·0 cites
- 1845US2007269802A1Ranbp2 as Modifiers of the Pten/Igf Pathway and Methods of UseEXELIXIS INC·Filed 2004·Application pending·0 cites
- 1941US2012107827A1PSMCs As Modifiers of the RB Pathway and Methods of UseTAI ALBERT K·Filed 2011·Application pending·0 cites
- 2039US2009013420A1Psmcs as Modifiers of the Rb Pathway and Methods of UseTAI ALBERT K·Filed 2003·Application pending·0 cites
- 2138US8758994B2CDK9 as modifier of the IGF pathway and methods of useMAXWELL MARK E·Filed 2005·Granted Jun 24, 2014·0 cites·6 claims
- 2238US8288119B2PGDS as modifiers of the PTEN pathway and methods of useSONG CHUNYAN·Filed 2005·Granted Oct 16, 2012·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →